View Author
patient methotrexate fumarate group methotrexate group paraganglioma fumarate group psoriasis treatment tumor mutation study vhl gene therapy vhl disease disease 12 weeks analysis event ef ficacy 27 patients pheochromocytoma plaque psoriasis baseline syndrome hippel-lindau germline randomized allele fallah arani psoriasis vulgaris trial result tumor cells von hippel-lindau disease 4 weeks difference baseline pasi fumaric acid esters case 1 chromosome value plaque 25 patients cell carcinomas 16 weeks ficacy marker endocrinol sequencing fallah metab 26 patients british krijger rr liver enzymes arani dermatologist mutation analysis fumarate therapy 15 mg laboratory severity index 855–861 author reduction addition family vulgari association cancer harbor vhl deletions vhl type 2. carcinoma vhl patients randomization inactivation lenders jw hemangioblastoma loh analysis
2 Most Recent Publications
|
Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial
(Article)
Fallah Arani, S Neumann, H.P. Hop, W.C.J. Thio, H.B. |
2011-04-01
|
|
Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome
(Article)
Gaal, J. Nederveen, F.H. van Erlic, Z. Korpershoek, E. Oldenburg, R. Boedeker, C.C. Kontny, U. Neumann, H.P. Dinjens, W.N.M. Krijger, R.R. de |
2009-11-01
|